ClinicalTrialsFinder

CLDN18.2 Positive Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Pancreatic Ductal AdenocarcinomaGastric/Gastroesophageal Junction AdenocarcinomaCLDN18.2 Positive
Innovent Biologics (Suzhou) Co. Ltd.389 enrolled1 locationNCT07483554